Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions.
- Author:
Na ZHANG
1
;
Zhen-zhu SUN
;
Feng LI
;
Yu-wen CAO
;
Chun-xia ZHAO
;
Wei-hua LIANG
;
Hua-peng SUN
;
Hong-an LI
;
Xin-ge FU
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Aged, 80 and over; Breast; pathology; Breast Neoplasms; genetics; metabolism; pathology; Carcinoma, Ductal, Breast; genetics; metabolism; pathology; Carcinoma, Intraductal, Noninfiltrating; genetics; metabolism; pathology; CpG Islands; genetics; DNA Methylation; DNA, Neoplasm; genetics; Disease Progression; Female; Humans; Hyperplasia; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Precancerous Conditions; genetics; metabolism; pathology; Promoter Regions, Genetic; Receptor, Notch1; genetics; metabolism; Young Adult
- From: Chinese Journal of Pathology 2011;40(5):324-329
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the relevance between the promoter methylation status of Notch1 gene and the invasive ductal carcinoma and ductal hyperplastic lesions of the breast.
METHODSMethylation status of Notch1 gene in human breast invasive ductal carcinoma (IDC, n = 89), ductal carcinoma in situ (DCIS, n = 20), atypical ductal hyperplasia (ADH, n = 11) and usual ductal hyperplasia (UDH, n = 20) were quantitatively evaluated by MALDI-TOF MS. The expression of Notch1 protein was detected by immunohistochemical stain (SP method).
RESULTSPositive expression rates of Notch1 protein in IDC and DCIS were 91.0% (81/89) and 75.0% (15/20), respectively, which were significantly higher than those of ADH (4/11) and UDH (30.0%, 6/20;P < 0.05). Notch1 protein expression was correlated significantly with lymph node metastasis, pathological grades and TNM stages of IDC. The mean methylation levels of Notch1 gene at CpG_3, CpG_4.5 and CpG_8 significantly decreased in IDC group compared with those of DCIS, ADH and UDH groups (P < 0.0083). In breast carcinomas, the mean methylation rates of Notch1 gene at CpG_4.5, CpG_10.11, and CpG_14.15.16 loci in cases with axillary node metastasis were significantly lower than those without axillary node metastasis (P < 0.05); and the methylation rates at CpG_14.15.16 and CpG_18 loci in stage Iwere lower than that in stage II, further lower than that in stage III (P < 0.05); and that in CpG_1.2, CpG_12.13 loci in grade I (highly-differentiated group) were higher than that in grade II (moderate-differentiated group) and grade III (poorly-differentiated group) (P < 0.05); and the methylation rates at CpG_3, CpG_8 and CpG_14.15.16 loci in ER(+) PR(+) HER2(-) group were lower than that in ER(-) PR(-) HER2(+) group (P < 0.05).
CONCLUSIONSThere is an overall hypomethylation of Notch1 gene in breast invasive ductal carcinomas with corresponding over-expression of Notch1 protein. This inverse correlation show that the alteration of protein expression result from hypomethylation oncogene Notch1, and this change may have important significance in breast tumorigenesis and the development. Specific hypomethylation at CpG_3, CpG_ 4.5 and CpG_8 loci of Notch1 gene may play a role in the pathogenesis of breast carcinoma, suggesting the progression and/or malignant transformation from benign glandular lesions of the breast.
